NCT07034664View on ClinicalTrials.gov

IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

July 30, 2027

Study Completion Date

September 30, 2027

Conditions
Crohn's DiseaseGuselkumabIntestinal UltrasoundPredictor
Trial Locations (1)

410000

RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER

NCT07034664 - IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study | Biotech Hunter | Biotech Hunter